The global bioactive wound care market was valued at USD 6.9 billion in 2015 and is expected to grow at a CAGR of 6.3% over the forecast period. Localized injury to the skin and underlying tissue results in conditions, such as pressure ulcers, bed sores, and diabetic foot.

1. Follow Us:
Bioactive Wound Care Market Analysis, Size, Growth, Share &
Forecast to 2024 | Grand View Research Inc.
The global Bioactive Wound Care Market is expected to reach USD 11.9 billion by 2024, according to a new
report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers,
diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line
of treatment, which act efficiently in curing the aforementioned conditions.
Hence, with the increasing target population, the bioactive wound care market is estimated to witness lucrative
growth. Rise in awareness among the patients regarding personal hygiene is augmenting the demand for
these products. The raised awareness levels cause patients to seek physicians’ advice at an early stage thus
enabling timely interventions.
Rising per capita healthcare expenditure in the recent years and the increasing disposable income is enabling
the population to spend a substantial amount on healthcare facilities, thereby contributing towards the growth
of the market. The development of advanced products, such as combination wound dressings containing
multiple ingredients that offer several benefits to patients, is anticipated to boost the demand for these
products.
Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/bioactive-wound-
care-market
“Bioactive Wound Care Market To Reach $11.9 Billion By 2024.”

2. Follow Us:
Further key findings from the study suggest:
• The moist wound care products segment held a lucrative share of more than 50.0% in 2015. The ability
of these products to create a supportive moist environment, which expedites the healing process, is a
notable feature of these products. Moist wound care products include foams, films, alginates,
hydrocolloids, and hydrogels.
• The antimicrobials segment, comprising products impregnated with silver and non-silver ingredients, is
anticipated to witness profitable growth over the forecast period. These products are cost efficient with
lower chances of developing resistance to antimicrobial products.
• The segment of active wound care products, likewise, is anticipated to exhibit a significant growth rate
in the coming 8 years. Recently, the U.S. Food and Drug Administration approved a couple of
biomaterials, Dermagraft, and Alpigraph, for management of skin-related injuries. The ability of these
products to mimic biological properties is a key advantage that enables a faster healing process.
• North America contributed with a share of more than 30.0% of the global bioactive wound care market.
Presence of major players, streamlined regulations, and favorable reimbursement policies are some of
the key contributing factors responsible for the growth of this region.
• Asia Pacific with its huge potential is anticipated to witness considerable growth over the forecast
period. The presence of a huge untapped population, stirring economic developments in this region,
and consistent efforts undertaken to improve the healthcare infrastructure are the key growth drivers.
• The key players in this industry include Smiths & Nephew, Mölnlycke Health Care, ConvaTec, Inc.,
Paul Hartmann AG, Organogenesis, Inc., Systagenix Wound Management Ltd., 3M Healthcare Ltd.,
Medtronic, Covalon Technologies Ltd., BSN Medical, and Medline Industries, Inc.
• The strategic endeavors undertaken by the leading players in the industry include new product
launches, collaborations with government bodies, and R&D investments.
• In July 2015, Smith & Nephew acquired DeOst LLC and DeLLC, part of the DeOST group, which is a
manufacturer of medical devices in Russia. This acquisition is expected to help companies expand their
global footprints.
Grand View Research has segmented the global bioactive wound care market on the basis of product and
region:
Global Bioactive Wound Care Market, By Product (USD Million), 2013 - 2024
• Moist Wound Care
o Foams
o Films
o Alginates

3. Follow Us:
o Hydrocolloids
o Hydrogels
• Antimicrobial Wound Care
o Silver-based
o Non-silver-based
• Active Wound Care
o Biomaterials
o Skin substituents
Bioactive Wound Care Market, By Region (USD Million), 2013 - 2024
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
• Asia Pacific
o Japan
o China
• Latin America
o Brazil
o Mexico
• MEA
o South Africa
o Saudi Arabia

4. Follow Us:
Table of Content
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Bioactive Wound Care Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Bioactive Wound Care Industry Outlook
3.1. Bioactive Wound Care Market Segmentation
3.2. Bioactive Wound Care Market Size and Growth Prospects
3.3. Bioactive Wound Care Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key Opportunities Prioritized
3.5. Industry Analysis: Porter's
3.6. Bioactive Wound Care Market PESTEL Analysis, 2015
Chapter 4. Bioactive Wound Care Market, by Product
4.1. Bioactive Wound Care Market Share, By Product, 2015 & 2024 (USD Million)
4.2. Moist Wound Care
4.2.1. Moist wound Care Market estimates and forecasts, 2013 - 2024 (USD Million)
4.2.2. Foam-based wound dressings
4.2.2.1. Foam-based wound dressings market estimates and forecasts, 2013 - 2024 (USD
Million)
4.2.3. Alginate wound dressings
4.2.3.1. Alginate wound dressings market estimates and forecasts, 2013 - 2024 (USD
Million)
4.2.4. Film
4.2.4.1. Film dressings market estimates and forecasts, 2013 - 2024 (USD Million)
4.2.5. Hydrocolloid
4.2.5.1. Hydrocolloid-based wound dressings market estimates and forecasts, 2013 - 2024
(USD Million)
4.2.6. Hydrogel
4.2.6.1. Hydrogel wound dressings market estimates and forecasts, 2013 - 2024 (USD
Million)

5. Follow Us:
4.3. Antimicrobial Wound Care
4.3.1. Silver-based wound dressings market estimates and forecasts, 2013 - 2024 (USD
Million)
4.3.2. Non-silver Wound Dressings
4.3.2.1. Non-silver wound dressings market estimates and forecasts, 2013 - 2024 (USD
Million)
4.4. Active Wound Care
4.4.1. Active wound Care Market estimates and forecasts, 2013 - 2024 (USD Million)
4.4.2. Biomaterial
4.4.2.1. Biomaterial dressings market estimates and forecasts, 2013 - 2024 (USD Million)
4.4.2.2. Skin substituents
4.4.2.3. Skin substituents market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 5. Bioactive Wound Care Market, By Region
5.1. Bioactive Wound Care Market Share, by Region,2015 & 2024 (USD Million)
5.2. North America
5.2.1. North America market estimates and forecasts, 2013 - 2024 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. market estimates and forecasts, 2013 - 2024 (USD Million)
5.2.2.2. U.S. market estimates and forecastsby product 2013 - 2024 (USD Million)
5.2.3. Canada
5.2.3.1. Canada market estimates and forecasts, 2013 - 2024 (USD Million)
5.2.3.2. Canada market estimates and forecasts,by product, 2013 - 2024 (USD Million)
5.3. Europe
5.3.1. Europe market estimates and forecasts, 2013 - 2024 (USD Million)
5.3.2. UK
5.3.2.1. UK market estimates and forecasts, 2013 - 2024 (USD Million)
5.3.2.2. UK market estimates and forecasts,by product, 2013 - 2024 (USD Million)
5.3.3. Germany
5.3.3.1. Germany market estimates and forecasts, 2013 - 2024 (USD Million)
5.3.3.2. Germany market estimates and forecasts,by product 2013 - 2024 (USD Million)
5.3.4. Asia Pacific Market Estimates and Forecasts , 2013 - 2024 (USD Million)
5.3.5. Japan
5.3.5.1. Japan market estimates and forecasts, 2013 - 2024 (USD Million)
5.3.5.2. Japan market estimates and forecasts,by product 2013 - 2024 (USD Million)

6. Follow Us:
5.3.6. China
5.3.6.1. China market estimates and forecasts, 2013 - 2024 (USD Million)
5.3.6.2. China market estimates and forecasts,by product 2013 - 2024 (USD Million)
5.4. Latin America
5.4.1. Latin America market estimates and forecasts, 2013 - 2024 (USD Million)
5.4.2. Brazil
5.4.2.1. Brazil market estimates and forecasts, 2013 - 2024 (USD Million)
5.4.2.2. Brazil market estimates and forecasts,by product 2013 - 2024 (USD Million)
5.4.3. Mexico
5.4.3.1. Mexico market estimates and forecasts, 2013 - 2024 (USD Million)
5.4.3.2. Mexico market estimates and forecasts,by product 2013 - 2024 (USD Million)
5.5. MEA
5.5.1. MEA market estimates and forecasts, 2013 - 2024 (USD Million)
5.5.2. South Africa
5.5.2.1. South Africa market estimates and forecasts, 2013 - 2024 (USD Million)
5.5.2.2. South Africa market estimates and forecasts,by product 2013 - 2024 (USD Million)
5.5.3. Saudi Arabia
5.5.3.1. Saudi Arabia market estimates and forecasts, 2013 - 2024 (USD Million)
5.5.3.2. Saudi Arabia market estimates and forecasts, by product 2013 - 2024 (USD
Million)
Chapter 6. Competitive Landscape
6.1. Smiths & Nephew
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. ConvaTec, Inc.
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Mölnlycke Health Care
6.3.1. Company Overview
6.3.2. Financial Performance

7. Follow Us:
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Paul Hartmann AG
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Systagenix Wound Management Ltd.
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Organogenesis Inc.
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. Medtronic
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. 3M Health Care
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. Covalon Technologies Ltd.
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. BSN Medical
6.10.1. Company Overview

8. Follow Us:
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives
6.11. Medline Industries
6.11.1. Company Overview
6.11.2. Financial Performance
6.11.3. Product Benchmarking
6.11.4. Strategic Initiatives
About Grand View Research, Inc.:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based research across a range of
industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com